# US 2016/0249808 A1 · Improved transcutaneous organ function measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0249808 A1
- Document ID: US20160249808A1
- Status: Published application
- Kind: A1
- Application number: 15/030,727
- Filed: 2014-10-20
- Published: 2016-09-01
- Earliest claimed: 2013-10-22
- Assignees: MediBeacon Inc.
- Inventors: Ralf HEINRICH; Johannes PILL; Sabine NEUDECKER; Daniel SCHOCK-KUSCH; Jurgen GUNTHER; Stefan KONIG; Jochen FRIEDMANN
- Web page: https://patentgrep.com/patent/US20160249808A1

## CPC

- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/201: {Assessing renal or kidney functions}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The present invention relates to a method for determining an organ function in a subject, comprising the steps of: providing a first concentration-time curve obtained by transcutaneously measuring in a body fluid at a first position background fluorescence in at least one first time point and fluorescence of an indicator compound in at least a second, a third, a fourth, a fifth, and a sixth time point; providing a second concentration curve obtained by transcutaneously measuring in a body fluid at a second position background fluorescence in at least one seventh time point and fluorescence of an indicator compound in at least a eighth, a ninth, a tenth, an eleventh, and a twelfth time point; fitting the first and the second concentration curve into a kinetic model representing at least four diffusion compartments; and thereby determining an organ function in a subject. The invention further relates to a device for determining an organ function according to the method of the present invention, said device comprising a first sensor for transcutaneously measuring fluorescence of an indicator at a first position, a second sensor for transcutaneously measuring fluorescence of an indicator at a second position; and a data processing unit for fitting the values obtained by the sensors into a kinetic model of one of the preceding claims. The present invention also relates to a kit comprising a device of the present invention and an indicator compound, as well as to a computer or computer network comprising at least one processor, wherein the computer or computer network is adapted to perform the method according to the present invention.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A method for determining an organ function in a subject, comprising the steps of:
a) providing a first concentration-time curve obtained by transcutaneously measuring in a body fluid at a first position (i) background fluorescence in at least one first time point and (ii) fluorescence of an indicator compound in at least a second, a third, a fourth, a fifth, and a sixth time point,
b) providing a second concentration-time curve obtained by transcutaneously measuring in a body fluid at a second position (i) background fluorescence in at least one seventh time point and (ii) fluorescence of an indicator compound in at least a eighth, a ninth, a tenth, an eleventh, and a twelfth time point,
c) fitting the first and the second concentration-time curve into a kinetic model representing at least four diffusion compartments, wherein the diffusion compartments represent an application compartment, plasma, interstitium, and a local interstitium, assigning parameters being either global or local, and
d) thereby determining an organ function in a subject,
wherein the first position is different from the second position, and wherein measuring fluorescence of an indicator compound at a first and a second position is performed simultaneously.

### Claim 18 (depends on 17)

The method of claim 17, wherein providing a first concentration-time curve in step a) is obtaining a first concentration-time curve by transcutaneously measuring in a body fluid at a first position (i) background fluorescence in at least one first time point and (ii) fluorescence of an indicator compound in at least a second, a third, a fourth, a fifth, and a sixth time point, and wherein providing a second concentration-time curve in step b) is obtaining a second concentration-time curve by transcutaneously measuring in a body fluid at a second position (i) background fluorescence in at least one seventh time point and (ii) fluorescence of an indicator compound in at least a eighth, a ninth, a tenth, an eleventh, and a twelfth time point.

### Claim 19 (depends on 17)

The method of claim 17, wherein said kinetic model is a kinetic model representing four diffusion compartments.

### Claim 20 (depends on 17)

The method of claim 17, wherein the organ function is the glomerular filtration rate (GFR).

### Claim 21 (depends on 17)

The method of claim 17, wherein the result of said fitting is the GFR per plasma volume of said subject.

### Claim 22 (depends on 21)

The method of claim 21, wherein the numeric value assigned to the total plasma volume of said subject is determined from the body mass of said subject.

### Claim 23 (depends on 17)

The method of claim 17, further comprising the step of administering an indicator compound to said subject, wherein said administering an indicator compound is preceded by the first and the seventh time point.

### Claim 24 (depends on 17)

The method of claim 17, wherein at least the second and the eighth time point are at most two hours after administering said indicator compound.

### Claim 25 (depends on 17)

The method of claim 17, wherein the indicator compound comprises a fluorescent low-molecular weight compound covalently bound to a hydrophilic compound, wherein the hydrophilic part is selected from the list consisting of oligo- and polysaccharides, oligo- and polyalcohols, and oligo- and polyethers.

### Claim 26 (depends on 17)

A device for determining an organ function according to the method of claim 17, said device comprising:
a) a first sensor for transcutaneously measuring fluorescence of an indicator at a first position,
b) a second sensor for transcutaneously measuring fluorescence of an indicator at a second position; and
c) a data processing unit for fitting the values obtained by the sensors into a kinetic model of one of the preceding claims,
wherein said first sensor and said second sensor are operatively linked in that the data processing unit of the device is configured to bring together the results of the measurements performed by said sensors and fits the data into a kinetic model representing at least four diffusion compartments.

### Claim 27 (depends on 26)

The device of claim 26, further comprising a data storage unit comprising at least reference values of total plasma volume correlated to body mass.

### Claim 28 (depends on 26)

A kit comprising the device of claim 26 and an indicator compound.

### Claim 29 (depends on 28)

The kit of claim 28, wherein the indicator compound comprises a fluorescent low-molecular weight compound covalently bound to a hydrophilic compound, wherein the hydrophilic part is selected from the list consisting of oligo- and polysaccharides, oligo- and polyalcohols, and oligo- and polyethers.

### Claim 30 (depends on 17)

A computer program, wherein the computer program is adapted to perform the method according to claim 17, while the program is being executed on a computer.

### Claim 31 (depends on 17)

A computer or computer network comprising at least one processor, wherein the computer or computer network is adapted to perform the method according to claim 17.
